Dolby Laboratories Inc (DLB) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.91 is considered Undervalued compared with the five-year average of 21.92. The fair price of Dolby Laboratories Inc (DLB) is between 288.72 to 312.72 according to relative valuation method. Compared to the current price of 64.74 USD , Dolby Laboratories Inc By Undervalued By 77.58%.

Relative Value

Fair Zone

288.72-312.72

Current Price：64.74

77.58%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Dolby Laboratories Inc (DLB) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Dolby Laboratories Inc (DLB) has a current Price-to-Book (P/B) ratio of 2.31. Compared to its 3-year average P/B ratio of 3.08, the current P/B ratio is approximately -24.92% higher. Relative to its 5-year average P/B ratio of 3.18, the current P/B ratio is about -27.34% higher. Dolby Laboratories Inc (DLB) has a Forward Free Cash Flow (FCF) yield of approximately 7.20%. Compared to its 3-year average FCF yield of 4.66%, the current FCF yield is approximately 54.55% lower. Relative to its 5-year average FCF yield of 4.43%, the current FCF yield is about 62.68% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for DLB competitors is 8.70, providing a benchmark for relative valuation. Dolby Laboratories Inc Corp (DLB.N) exhibits a P/S ratio of --, which is -100% above the industry average. Given its robust revenue growth of -2.88%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of DLB increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of DLB in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is DLB currently overvalued or undervalued?

What is Dolby Laboratories Inc (DLB) fair value?

DLB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Dolby Laboratories Inc (DLB) is between 288.72 to 312.72 according to relative valuation method.

How does DLB's valuation metrics compare to the industry average?

The average P/S ratio for DLB's competitors is 8.70, providing a benchmark for relative valuation. Dolby Laboratories Inc Corp (DLB) exhibits a P/S ratio of --, which is -100.00% above the industry average. Given its robust revenue growth of -2.88%, this premium appears unsustainable.

What is the current P/B ratio for Dolby Laboratories Inc (DLB) as of Mar 04 2026?

As of Mar 04 2026, Dolby Laboratories Inc (DLB) has a P/B ratio of 2.31. This indicates that the market values DLB at 2.31 times its book value.

What is the current FCF Yield for Dolby Laboratories Inc (DLB) as of Mar 04 2026?

As of Mar 04 2026, Dolby Laboratories Inc (DLB) has a FCF Yield of 7.20%. This means that for every dollar of Dolby Laboratories Inc's market capitalization, the company generates 7.20 cents in free cash flow.

What is the current Forward P/E ratio for Dolby Laboratories Inc (DLB) as of Mar 04 2026?

As of Mar 04 2026, Dolby Laboratories Inc (DLB) has a Forward P/E ratio of 14.91. This means the market is willing to pay $14.91 for every dollar of Dolby Laboratories Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Dolby Laboratories Inc (DLB) as of Mar 04 2026?

As of Mar 04 2026, Dolby Laboratories Inc (DLB) has a Forward P/S ratio of 4.28. This means the market is valuing DLB at $4.28 for every dollar of expected revenue over the next 12 months.

DLB Valuation